CooperCompanies (NASDAQ: COO) has announced its financial results for the fiscal third quarter ending July 31, 2024. The company reported a revenue increase of 8% year-over-year to $1,002.8 million.
Barchart on MSN
The Cooper Companies’ Q2 2026 earnings: What to expect
San Ramon, California-based The Cooper Companies, Inc. (COO) is a global medical device company that develops and ...
Zacks Investment Research on MSN
Reasons to retain Cooper Companies stock in your portfolio for now
The Cooper Companies, Inc.’s COO growth is fueled by CooperVision’s premium lens migration and MiSight’s myopia-management leadership, supported by CooperSurgical’s women’s health and fertility ...
Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark Global Fund”. A copy of the letter can be downloaded here.
COO's premium lens, myopia control and fertility momentum support growth, but Asia-Pacific weakness and margin pressure keep the outlook measured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results